HLA Typing and Antibody Screening Reagents

The National Institutes of Health (NIH) Clinical Center's HLA Laboratory requires a one-year supply of specific HLA typing and antibody screening reagents from One Lambda, Inc. These reagents are critical for patient testing and transplantation protocols. One Lambda is the sole manufacturer of these specific reagents, and changing vendors would necessitate extensive validation, significantly impacting the lab's ability to provide timely results. The acquisition will be conducted on a firm-fixed-price, sole-source basis, utilizing simplified acquisition procedures.